Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community

Annals of Hepatology

Volumn 10, Issue 2, 2011, Pages 119-124

  Onyekwere, Charles Asabamaka ^a   Ogbera, Anthonia O ^a   Balogun, Babajide O ^a  

^a LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

Author keywords

African; Diabetes; Liver ultrasound; Metabolic syndrome; Non alcoholic fatty liver

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; HEPATITIS B ANTIGEN; HEPATITIS C ANTIBODY;

ABDOMINAL RADIOGRAPHY; ADULT; AFRICA; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL SERVICE; HUMAN; HYPERTRANSAMINASEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; SEX RATIO; URBAN AREA; WAIST CIRCUMFERENCE;

EID: 79956057030     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31559-5     Document Type: Article

References (22)

1. Guerrero R, Vega GL, Grundy SM, Browning JD. Ethnic differences in hepatic steatosis: an insulin resistance paradox? Hepatology 2009; 49: 791-801.
2. Sears D. Fatty liver: Available at www.Medscape.com/viewarticle/588890 accessed 8/7/2010.
3. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120(16): 1640-1605.
4. Deedwania PC, Gupta R: Management issues in the metabolic syndrome. J Assoc Physicians India 2006; 54: 797-810.
5. Ogbera A. Prevalence and gender distribution of the metabolic syndrome. Diabetology & Metabolic Syndrome 2010; 2: 1doi:10.1186/1758-5996-2-1.
6. Graham RC, Burke A, Stettler N. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents. J Pediatr Gas-troenterol Nutr 2009; 49(4): 442-449.
7. Adams LA, Lymp JF, Sauver J, Sanderson SO, Lindor K D, Feldstein A, Angulo P. The natural history of NAFLD; a population-based cohort study. Gastroenterology 2005; 129: 113-121.
8. Hui JM, Hodge A, Farell GC, Kench JG, Kriketos A, George J. Beyond Insulin resistance in NASH; TNF alpha or adipo-nectin. Hepatology 2004; 40: 46-54.
9. Younossi ZM. Current management of NAFLD and NASH. Alim Pharm & Therapeutics 2008; 28(1): 2-12.
10. Mishra P, Younossi ZM. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gas-troenterol 2007; 102(12): 2716-2717.
11. Lesi OA, Soyebi KS, Eboh CN Fatty liver in a cohort of HIV positive Africans on HAART. J Nat Med Assoc 2009; 101: 151-155.
12. Schumann G, Bonora R, Ceriotti F, Férard G, Ferrero CA, Franck PF, Siekmann L, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 5. Reference procedure for the measurement of catalytic concentration of aspar-tate aminotransferase. Clin Chem Lab Med 2002; 40(7): 725-733.
13. Abell LL, Levy BB, Brodie BB, Kendall FE. Simplified methods for the estimation of the total cholesterol in serum and demonstration of specificity. J Biol Chem 1952; 195: 357-366.
14. Lopez-Virella ML: Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977; 23: 882-890.
15. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476-582.
16. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultra centrifuge. Clin Chem 1972; 18: 499-502.
17. Corrao G, Bagnardi V, Zambon A, La Vecchia MC. A meta-analysis of alcohol consumption and the risk of 15 diseases Preventive Medicine Volume 2004; 38(5): 613-9.
18. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO/IDF Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Org; 2006.
19. Ivashkin V, Drapkina O, Ashikhmin Y. Prevalence and risk factors for non alcoholic fatty liver disease in Russian Federation.(abstract 330). J Hepatol 2010; (Suppl.).
20. Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, Wasada T. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabetic Medicine 2005; 22: 1141-1145.
21. Clinical practice committee AGA. AGA Technical review on NAFLD. Gastroenterology 2002; 123: 1705-1725.
22. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver disease in a general population of Okinawa, Japan. Japan J Med 1988; 27(2): 142-149.